HUMATE-P®

Humate-P®

FDA INDICATION: Hemophilia A — Treatment and prevention of bleeding in adults. Von Willebrand disease (vWD) — in adults and pediatric patients in the (i) treatment of spontaneous and trauma-induced bleeding episodes; it is not indicated for the prophylaxis of spontaneous bleeding episodes, and (ii) prevention of excessive bleeding during and after surgery. This applies to patients with severe vWD as well as patients with mild to moderate vWD where the use of desmospressin is known or suspected to be inadequate. Package Insert

CLASS: Plasma-Derived

DISTRIBUTOR: CSL Behring

ASSAY SIZE (IU): FVIII: 250, 500, 1000
VWF:RCo: 600, 1200, 2400

DILUENT SIZE: 5.0 mL (250 IU FVIII, 600 IU VWF:RCo), 10.0 mL (500 IU FVIII, 1200 IU VWF:RCo), 15.0 mL (1000 IU FVIII, 2400 IU VWF:RCo)

MIXING DEVICE: Mix2Vial®

ROOM TEMPERATURE STORAGE: 24 months

HALF-LIFE: Mean 12.2 hours (FVIII), Median 11.0 hours (VWF:RCo)

OTHER WEBSITES: cslbehring.comhumate-p.com